“sage-therapeutics” Archives

in
Entry Author Date Location
Praxis Precision Medicines Leads Way as Three More Biotechs Prep IPOs 09/28/20 Boston
Biotech Roundup: GSK’s Ante, Shakeup at Sage, Telehealth’s Rise & More 04/10/20 National
Sage Restructuring Halves Staff, Turns Focus to Failed Depression Drug 04/07/20 Boston
Bio Roundup: Biogen at CTAD, Sage’s Stumble, Astellas’s $3B Offer & More 12/06/19 National
Sage Therapeutics Depression Drug Fails in Phase 3, Shares Fall 60% 12/05/19 Boston
The Placebo Effect Is Hobbling New Psychiatric Drugs. What Can Stop It? 10/10/19 National
Bio Roundup: Award Winners, Lung Data, Dems on Drug Pricing & More 09/13/19 National
The Winners of the 2019 Xconomy Awards Boston Are… 09/12/19 Boston
Bio Roundup: Leiden’s Exit, Depression Data, a New Pricing Bill & More 07/26/19 National
The Finalists for the 2019 Xconomy Awards Are … 07/10/19 Boston
Bio Roundup: Sage Postpartum Help, Biogen Bids Adu, Heart Beats & More 03/22/19 National
FDA OKs Depression Drug For New Moms: Fast Relief But Tough to Take 03/19/19 Boston
The Life, Troubles, and Celgene Legacy of Deal Guru George Golumbeski 03/11/19 National
Bio Roundup: #JPM19 Notes, Loxo Buyout, Black Diamond’s Cash & More 01/11/19 National
Bio-JPM Roundup: Lilly Buys Loxo, Sage’s Stock Soars, ALS Cash & More 01/07/19 National
Sage Hits Mark in Postpartum Depression Phase 3 Trial, Stock Surges 01/07/19 Boston
15 for ’19: Key Clinical Data to Watch for Next Year (Part 1) 12/17/18 National
Bio Roundup: Eli Lilly Tries Tau, Generic Insulin, NASH Cash & More 12/14/18 National
Marinus Claims Phase 2 Postpartum Depression Win, Analysts Less Sure 12/10/18 Boston
With FDA Panel’s Nod, First Postpartum Depression Drug Nears Approval 11/02/18 Boston
Bio Roundup: Depression Drug Dashed, Peek at ASH, CRISPR Worry & More 11/02/18 National
The Art of Perseverance: Meet Xconomy’s Six CEO Award Finalists 07/02/18 Boston
The 2018 Xconomy Awards Finalists Are… 06/28/18 Boston
Bio Roundup: Not-BIO Party Foul, CRISPR Drama, Sickle Cell Updates 06/15/18 National
Sage Speeds Ahead With Plans For a Short-Course Depression Drug 06/12/18 Boston
Biotech Roundup: ASCO Ahead, CAMP4’s Cash, Ambien Tweeting & More 06/01/18 National
Bio Roundup: CRISPR Tests, Parkinson’s Questions, Opioid Bills & More 04/27/18 National
Sage Postpartum Depression Drug Heads to FDA Review 04/23/18 Boston
Bio Roundup: Wilson’s Warning, Amazon’s Health Biz, Moderna Cash & More 02/02/18 National
Bio Roundup: Trials to Watch, Mega Deals, Video Game Therapy & More 12/08/17 Boston
Page 1 of 3 next page »